Siegfried Holding AG engages in the life sciences business worldwide. The company develops and produces active pharmaceutical ingredients (APIs) and intermediates, as well as finished dosage forms, including solid oral dosage forms, and sterile and aseptic filling injectables, ophthalmics, and inhalative products. It offers contract development and manufacturing services, including pharmaceutical and analytical development, process and analytical transfer, commercial manufacturing and packaging, and scale up and clinical trial material production. In addition, the company provides APIs and controlled substances focusing on anesthetics, pain treatment applications, and central nervous and respiratory diseases. Further, it licenses oral solid and sterile products; assembles registration dossiers; and offers a common technical document for various products. The company was founded in 1873 and is headquartered in Zofingen, Switzerland.

Siegfried Holding AG

Siegfried AG is a contract development and manufacturing organization that produces pharmaceutical ingredients and finished products as an integrated supplier. It leverages its pharmaceutical and chemical experience to take innovations to industrial scale.

msh id	CH:SIEGFRIED
symbol	SFZN
name	Siegfried Holding AG
homepage url	https://www.siegfried.ch
country	CH
sector	-
industry	-
market	STOCKS
employee count	3.63K
crunchbase url	-
linkedin url	-
founders	-

market cap	4.19B
enterprise value	-
stage	-
raised capital	-
valuation	-

monthly webtraffic	-
monthly webtraffic growth	-
growth score 14	-
growth score 28	-
growth score 90	-
growth score 365	-

revenue ltm	-
gross profit ltm	-
ebitda ltm	-
net income ltm	-
revenue ntm	-
gross profit ntm	-
ebitda ntm	-
net income ntm	-

growth cost and expenses	0.1
growth cost of revenue	0.04
growth depreciation and amortization	-0.01
growth ebitda	-0.23
growth ebitda ratio	-0.26
growth eps	-
growth eps diluted	-
growth general and administrative expenses	2.57
growth gross profit	0.01
growth gross profit ratio	-0.03

CH:SIEGFRIED

Siegfried AG

Last Close

1,100.00

21/11 16:31

Market Cap

3.63B

Beta: -

Volume Today

4.95K

Avg: -

Company Information

Market Metrics

Web & Growth Metrics

LTM & NTM Metrics

Growth & Performance Metrics

Operating Metrics

Balance Sheet Metrics

Financial Metrics (2022-2026)

cost and expenses	1.22B
cost of revenue	1.22B
depreciation and amortization	89.83M
ebitda	262.39M
ebitda ratio	0.19
eps	29.38
eps diluted	28.95
operating expenses	167.55M
operating income	190M
operating income ratio	0.14

accounts receivables	-19.65M
capital expenditure	-151.38M
cash at beginning of period	101.02M
cash at end of period	62.24M
inventory	476.95M
working capital ttm	627.29M

	2022	2023	2024	2025	2026
Revenue Metrics
Revenue	-	-	-	-	-
Revenue Growth	-	-	-	-	-
Revenue Multiple	-	-	-	-	-
Profit Metrics
Gross Profit	-	-	-	-	-
Gross Profit Growth	-	-	-	-	-
Gross Profit Multiple	-	-	-	-	-
EBITDA Metrics
EBITDA	-	-	-	-	-
EBITDA Growth	-	-	-	-	-
EBITDA Multiple	-	-	-	-	-
Net Income Metrics
Net Income	-	-	-	-	-
Net Income Growth	-	-	-	-	-
Net Income Multiple	-	-	-	-	-